A new era in wound care, combining regenerative biology and real-time AI precision.
Paracrine is transforming the way chronic wounds are treated — not with patches, but with precision.
We combine regenerative therapy, derived from the patient's own body, with real-time AI to deliver healing that's fast, predictable, and lasting. Our Stromal Vascular Therapy (SVT) has shown a 95% success rate in even the most difficult cases — often with just a single treatment.
With activities across the U.S., U.K., Japan, India, Turkey, Brazil, and China, we're building a global platform for biologically intelligent healing — scalable, cost-effective, and radically more human.
Autologous regenerative cells, extracted from the patient's fat, applied directly to the wound site — initiating a fast, targeted, and durable healing process.
Built to maximize the precision, efficiency, and outcomes of SVT:
Predicts healing likelihood and time-to-closure.
Flags patients unlikely to respond to standard care.
Enables remote follow-up via mobile and imaging.
Models total cost-of-care and payer ROI.
Identifies new indications using real-world data.
wound closure rate, even in 'never heal' cases
Healing in as little as 6 weeks
10,000+ patients treated safely and effectively
No reported recurrences
And less than USD $1,000 per treatment.
Whether you're a clinician, health system, or investor – we're building the platform that changes lives.
FDA 510(k) cleared. Partnering with top centers
CE Mark certified. Adopted by NHS centers
Strategic partnerships and regulatory expansion underway.
Strategic partnerships and regulatory expansion underway.
Strategic partnerships and regulatory expansion underway.
Strategic partnerships and regulatory expansion underway.
Strategic partnerships and regulatory expansion underway.
